Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HQK3
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0016289 | CoA hydrolase activity | 5 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016790 | thiolester hydrolase activity | 4 | 1 |
GO:0047617 | acyl-CoA hydrolase activity | 6 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 77 | 81 | PF00656 | 0.349 |
CLV_PCSK_KEX2_1 | 60 | 62 | PF00082 | 0.591 |
CLV_PCSK_PC1ET2_1 | 60 | 62 | PF00082 | 0.666 |
CLV_PCSK_SKI1_1 | 36 | 40 | PF00082 | 0.560 |
DOC_CYCLIN_yCln2_LP_2 | 53 | 59 | PF00134 | 0.622 |
DOC_MAPK_gen_1 | 120 | 130 | PF00069 | 0.408 |
DOC_PP1_RVXF_1 | 34 | 41 | PF00149 | 0.477 |
DOC_USP7_MATH_1 | 74 | 78 | PF00917 | 0.495 |
DOC_WW_Pin1_4 | 38 | 43 | PF00397 | 0.596 |
LIG_BRCT_BRCA1_1 | 106 | 110 | PF00533 | 0.331 |
LIG_BRCT_BRCA1_1 | 97 | 101 | PF00533 | 0.256 |
LIG_Clathr_ClatBox_1 | 121 | 125 | PF01394 | 0.248 |
LIG_FHA_1 | 117 | 123 | PF00498 | 0.309 |
LIG_FHA_1 | 129 | 135 | PF00498 | 0.353 |
LIG_FHA_1 | 146 | 152 | PF00498 | 0.531 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.650 |
LIG_LIR_Gen_1 | 127 | 135 | PF02991 | 0.296 |
LIG_LIR_Gen_1 | 80 | 90 | PF02991 | 0.319 |
LIG_LIR_Nem_3 | 127 | 133 | PF02991 | 0.296 |
LIG_LIR_Nem_3 | 80 | 85 | PF02991 | 0.319 |
LIG_Pex14_2 | 101 | 105 | PF04695 | 0.233 |
LIG_SH2_STAP1 | 30 | 34 | PF00017 | 0.652 |
LIG_SH2_STAT3 | 90 | 93 | PF00017 | 0.193 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.386 |
LIG_UBA3_1 | 7 | 14 | PF00899 | 0.403 |
MOD_CDC14_SPxK_1 | 41 | 44 | PF00782 | 0.648 |
MOD_CDK_SPxK_1 | 38 | 44 | PF00069 | 0.647 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.363 |
MOD_CK1_1 | 49 | 55 | PF00069 | 0.526 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.400 |
MOD_GlcNHglycan | 30 | 33 | PF01048 | 0.632 |
MOD_GSK3_1 | 124 | 131 | PF00069 | 0.433 |
MOD_GSK3_1 | 145 | 152 | PF00069 | 0.548 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.642 |
MOD_GSK3_1 | 97 | 104 | PF00069 | 0.301 |
MOD_N-GLC_1 | 28 | 33 | PF02516 | 0.561 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.390 |
MOD_NEK2_1 | 101 | 106 | PF00069 | 0.314 |
MOD_NEK2_1 | 124 | 129 | PF00069 | 0.319 |
MOD_NEK2_1 | 34 | 39 | PF00069 | 0.736 |
MOD_NEK2_2 | 66 | 71 | PF00069 | 0.566 |
MOD_PIKK_1 | 60 | 66 | PF00454 | 0.561 |
MOD_PKA_1 | 60 | 66 | PF00069 | 0.660 |
MOD_PKA_2 | 145 | 151 | PF00069 | 0.559 |
MOD_PKA_2 | 60 | 66 | PF00069 | 0.670 |
MOD_Plk_1 | 101 | 107 | PF00069 | 0.303 |
MOD_Plk_1 | 124 | 130 | PF00069 | 0.307 |
MOD_Plk_2-3 | 97 | 103 | PF00069 | 0.335 |
MOD_Plk_4 | 124 | 130 | PF00069 | 0.351 |
MOD_Plk_4 | 49 | 55 | PF00069 | 0.599 |
MOD_ProDKin_1 | 38 | 44 | PF00069 | 0.599 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PFU0 | Leptomonas seymouri | 68% | 100% |
A0A0S4JPU2 | Bodo saltans | 33% | 100% |
A0A1X0NLI9 | Trypanosomatidae | 45% | 100% |
A0A3S7XCF9 | Leishmania donovani | 77% | 100% |
A0A422NVU3 | Trypanosoma rangeli | 49% | 100% |
A4ICC1 | Leishmania infantum | 78% | 100% |
D0A3Q4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 100% |
E9AUB6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |
Q4Q074 | Leishmania major | 77% | 100% |